Defective CYP11B2 causes CMO-1 deficiency
REACTOME PATHWAYThe Defective CYP11B2 causes CMO-1 deficiency pathway (Reactome ID: R-HSA-5579009) involves 1 genes and is affected by 3 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Defective CYP11B2 causes CMO-1 deficiency
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Fadrozole | — | 300 |
| 2 | Etomidate Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or | — | 299 |
| 3 | Letrozole | — | 298 |
About the Defective CYP11B2 causes CMO-1 deficiency Pathway
The Defective CYP11B2 causes CMO-1 deficiency pathway is catalogued in Reactome (ID: R-HSA-5579009) and involves 1 genes. In the BiohacksAI corpus, 3 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CYP11B2.